EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pre-Clinical Research Advancements Relating to Improving the Diagnosis and Treatment of Malignant Pleural Mesothelioma: A Review

Ben Johnson, Kenneth Lee, Yuen Yee Cheng

Onco · 2021

DOI: 10.3390/onco1020006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Onco, 2021. Verfasst von Ben Johnson und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 214 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant pleural mesothelioma (MPM) is a rare, aggressive cancer of the lung lining that is predominantly associated with occupational exposure to asbestos. MPM is responsible for thousands of deaths worldwide every year, with the median survival of MPM of 8–14 months. There are limited biomarkers available in the clinic to effectively diagnose MPM, an invasive biopsy procedure is usually required to provide a definitive diagnosis. Due to the long latency period associated with MPM disease presentation, the cancer is usually at an advanced stage at the time of diagnosis where treatment options are largely ineffective at controlling disease progression. Previous MPM-based pre-clinical studies have made significant strides in determining the exact molecular mechanisms associated with asbestos carcinogenesis. Exploring less invasive blood-based biomarkers and treatment strategies involving targeted therapy, immunotherapy, and virotherapy is particularly important. Research in these areas is of crucial importance in relation to improving the rate of novel diagnostic biomarkers and treatment strategies progressing through to clinical trials and ultimately into the clinical setting. This review comprehensively summarises both previous and current pre-clinical research developments that have specifically contributed to an improved understanding of MPM disease biology, and the development of novel diagnostic biomarkers and treatment strategies.

Zitieren

APA

Johnson, B., Lee, K., & Cheng, Y. Y. (2021). Pre-Clinical Research Advancements Relating to Improving the Diagnosis and Treatment of Malignant Pleural Mesothelioma: A Review. Onco. https://doi.org/10.3390/onco1020006

Vancouver

Johnson B, Lee K, Cheng YY. Pre-Clinical Research Advancements Relating to Improving the Diagnosis and Treatment of Malignant Pleural Mesothelioma: A Review. Onco. 2021. doi:10.3390/onco1020006

BibTeX
@article{Johnson2021,
  author = {Johnson, Ben and Lee, Kenneth and Cheng, Yuen Yee},
  title = {Pre-Clinical Research Advancements Relating to Improving the Diagnosis and Treatment of Malignant Pleural Mesothelioma: A Review},
  journal = {Onco},
  year = {2021},
  doi = {10.3390/onco1020006}
}
Kostenlos starten →